StonvexLoading…
StonvexStonvexStonvexCore line items from CHKP's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $2.73B | $2.56B | $2.41B | $2.33B |
Operating Income | $831.10M | $876.00M | $899.10M | $884.30M |
Net Income | $1.06B | $845.70M | $840.30M | $796.90M |
EPS (Diluted) | $9.62 | $7.46 | $7.10 | $6.31 |
Total Assets | $7.81B | $5.75B | $5.70B | $5.72B |
Total Liabilities | $4.92B | $2.97B | $2.87B | $2.80B |
Cash & Equivalents | $1.80B | $506.20M | $537.70M | $196.00M |
Free Cash Flow OCF − CapEx | $1.17B | $1.03B | $1.02B | $1.08B |
Shares Outstanding | 105.60M | 108.37M | 112.91M | 120.76M |